We are a clinical stage biopharmaceutical company developing developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases. We have developed two highly promising pipelines of clinical and pre-clinical candidates with a focus on cancer and auto-immune diseases: - OncoMimics™: highly effective, off-the-shelf therapeutic vaccines against cancers (EO2401, EO2463). EO2401 is in Phase 1/2 clinical trials in patients with glioblastoma and adrenal tumors. EO2463 is in a Phase 1/2 clinical trial for indolent non-Hodgkin B-cell lymphomas. - EndoMimics™: a pipeline of next generation bioactives acting like human hormones or cytokines for the treatment of immune diseases. EB1010, the lead candidate, is designed to provide improved therapeutic outcomes for patients with IBD. In addition, Enterome’s clinical candidate sibofimloc (also referred to as TAK-018) is advancing through a Phase 2 clinical trial in post-operative Crohn’s disease. Sibofimloc has been partnered with Takeda globally, with Enterome retaining a significant profit share in the US.
View Top Employees from EnteromeWebsite | http://www.enterome.com |
Revenue | $33.8 million |
Funding | $126.4 million |
Employees | 83 (73 on RocketReach) |
Founded | 2011 |
Address | 94-96 Ave Ledru-rollin, Paris, Ile-de-France 75011, FR |
Phone | +33 1 75 77 27 85 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Microbiome, Manufacturing, Science and Engineering, Therapeutics, Health Care, Inflammatory Bowel Disease, Health Diagnostics, Companion Diagnostic, Metagenomics |
Web Rank | 8 Million |
Keywords | Enterome, Enterome Glioblastoma, Microbiome And Cancer |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 62151 Companies, NAICS Code 32 Companies, NAICS Code 62 Companies, NAICS Code 3254 Companies |
Looking for a particular Enterome employee's phone or email?
The Enterome annual revenue was $33.8 million in 2024.
Jan Fagerberg is the Chief Medical Officer of Enterome.
73 people are employed at Enterome.
Enterome is based in Paris, Ile-de-France.
The NAICS codes for Enterome are [6215, 621, 325, 32541, 62151, 32, 62, 3254].
The SIC codes for Enterome are [28, 283].